nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Cutaneous hypersensitivity—Chlorambucil—ovarian cancer	0.0605	0.0605	CcSEcCtD
Betahistine—Cutaneous hypersensitivity—Melphalan—ovarian cancer	0.0527	0.0527	CcSEcCtD
Betahistine—Cutaneous hypersensitivity—Docetaxel—ovarian cancer	0.0263	0.0263	CcSEcCtD
Betahistine—Digestion impaired—Chlorambucil—ovarian cancer	0.0221	0.0221	CcSEcCtD
Betahistine—Dermatitis atopic—Chlorambucil—ovarian cancer	0.02	0.02	CcSEcCtD
Betahistine—Digestion impaired—Melphalan—ovarian cancer	0.0193	0.0193	CcSEcCtD
Betahistine—Dermatitis atopic—Melphalan—ovarian cancer	0.0174	0.0174	CcSEcCtD
Betahistine—Convulsion—Altretamine—ovarian cancer	0.0157	0.0157	CcSEcCtD
Betahistine—Vasodilation—Vinorelbine—ovarian cancer	0.0128	0.0128	CcSEcCtD
Betahistine—Vasodilation procedure—Vinorelbine—ovarian cancer	0.0128	0.0128	CcSEcCtD
Betahistine—Fatigue—Altretamine—ovarian cancer	0.0128	0.0128	CcSEcCtD
Betahistine—Asthenia—Altretamine—ovarian cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Dermatitis atopic—Paclitaxel—ovarian cancer	0.0102	0.0102	CcSEcCtD
Betahistine—Dizziness—Altretamine—ovarian cancer	0.0098	0.0098	CcSEcCtD
Betahistine—Vomiting—Altretamine—ovarian cancer	0.00943	0.00943	CcSEcCtD
Betahistine—Nausea—Altretamine—ovarian cancer	0.00881	0.00881	CcSEcCtD
Betahistine—Dermatitis atopic—Docetaxel—ovarian cancer	0.00866	0.00866	CcSEcCtD
Betahistine—Ventricular extrasystoles—Paclitaxel—ovarian cancer	0.00838	0.00838	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00819	0.00819	CcSEcCtD
Betahistine—Bronchospasm—Melphalan—ovarian cancer	0.00794	0.00794	CcSEcCtD
Betahistine—Hallucination—Chlorambucil—ovarian cancer	0.00738	0.00738	CcSEcCtD
Betahistine—Erythema multiforme—Chlorambucil—ovarian cancer	0.00701	0.00701	CcSEcCtD
Betahistine—Bronchospasm—Vinorelbine—ovarian cancer	0.00694	0.00694	CcSEcCtD
Betahistine—Immune system disorder—Topotecan—ovarian cancer	0.00596	0.00596	CcSEcCtD
Betahistine—Angioedema—Chlorambucil—ovarian cancer	0.0059	0.0059	CcSEcCtD
Betahistine—Dermatitis atopic—Epirubicin—ovarian cancer	0.00584	0.00584	CcSEcCtD
Betahistine—Immune system disorder—Melphalan—ovarian cancer	0.00584	0.00584	CcSEcCtD
Betahistine—Convulsion—Chlorambucil—ovarian cancer	0.00559	0.00559	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—ovarian cancer	0.00541	0.00541	CcSEcCtD
Betahistine—Ill-defined disorder—Topotecan—ovarian cancer	0.00533	0.00533	CcSEcCtD
Betahistine—Confusional state—Chlorambucil—ovarian cancer	0.00531	0.00531	CcSEcCtD
Betahistine—Angioedema—Topotecan—ovarian cancer	0.00525	0.00525	CcSEcCtD
Betahistine—Malaise—Topotecan—ovarian cancer	0.00518	0.00518	CcSEcCtD
Betahistine—Immune system disorder—Vinorelbine—ovarian cancer	0.0051	0.0051	CcSEcCtD
Betahistine—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00502	0.00502	CcSEcCtD
Betahistine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00502	0.00502	CcSEcCtD
Betahistine—Vasodilation—Epirubicin—ovarian cancer	0.00492	0.00492	CcSEcCtD
Betahistine—Vasodilation procedure—Epirubicin—ovarian cancer	0.00492	0.00492	CcSEcCtD
Betahistine—Convulsion—Melphalan—ovarian cancer	0.00488	0.00488	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00486	0.00486	CcSEcCtD
Betahistine—Discomfort—Topotecan—ovarian cancer	0.00483	0.00483	CcSEcCtD
Betahistine—Ventricular extrasystoles—Epirubicin—ovarian cancer	0.00479	0.00479	CcSEcCtD
Betahistine—Abdominal distension—Paclitaxel—ovarian cancer	0.00478	0.00478	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00476	0.00476	CcSEcCtD
Betahistine—Anaphylactic shock—Topotecan—ovarian cancer	0.00469	0.00469	CcSEcCtD
Betahistine—Dyspepsia—Chlorambucil—ovarian cancer	0.00464	0.00464	CcSEcCtD
Betahistine—Nervous system disorder—Topotecan—ovarian cancer	0.0046	0.0046	CcSEcCtD
Betahistine—Anaphylactic shock—Melphalan—ovarian cancer	0.00459	0.00459	CcSEcCtD
Betahistine—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00456	0.00456	CcSEcCtD
Betahistine—Skin disorder—Topotecan—ovarian cancer	0.00456	0.00456	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—ovarian cancer	0.00455	0.00455	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—ovarian cancer	0.00455	0.00455	CcSEcCtD
Betahistine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00455	0.00455	CcSEcCtD
Betahistine—Fatigue—Chlorambucil—ovarian cancer	0.00454	0.00454	CcSEcCtD
Betahistine—Angioedema—Vinorelbine—ovarian cancer	0.00449	0.00449	CcSEcCtD
Betahistine—Tachycardia—Melphalan—ovarian cancer	0.00448	0.00448	CcSEcCtD
Betahistine—Skin disorder—Melphalan—ovarian cancer	0.00446	0.00446	CcSEcCtD
Betahistine—Malaise—Vinorelbine—ovarian cancer	0.00443	0.00443	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.00443	0.00443	CcSEcCtD
Betahistine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00434	0.00434	CcSEcCtD
Betahistine—Abdominal pain upper—Docetaxel—ovarian cancer	0.00425	0.00425	CcSEcCtD
Betahistine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.00425	0.00425	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.0042	0.0042	CcSEcCtD
Betahistine—Urticaria—Chlorambucil—ovarian cancer	0.00419	0.00419	CcSEcCtD
Betahistine—Dyspnoea—Topotecan—ovarian cancer	0.00418	0.00418	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00416	0.00416	CcSEcCtD
Betahistine—Discomfort—Vinorelbine—ovarian cancer	0.00414	0.00414	CcSEcCtD
Betahistine—Dyspepsia—Topotecan—ovarian cancer	0.00413	0.00413	CcSEcCtD
Betahistine—Dyspnoea—Melphalan—ovarian cancer	0.00409	0.00409	CcSEcCtD
Betahistine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00405	0.00405	CcSEcCtD
Betahistine—Fatigue—Topotecan—ovarian cancer	0.00404	0.00404	CcSEcCtD
Betahistine—Dyspepsia—Melphalan—ovarian cancer	0.00404	0.00404	CcSEcCtD
Betahistine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00401	0.00401	CcSEcCtD
Betahistine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00397	0.00397	CcSEcCtD
Betahistine—Fatigue—Melphalan—ovarian cancer	0.00396	0.00396	CcSEcCtD
Betahistine—Bronchospasm—Docetaxel—ovarian cancer	0.00396	0.00396	CcSEcCtD
Betahistine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00394	0.00394	CcSEcCtD
Betahistine—Tachycardia—Vinorelbine—ovarian cancer	0.00392	0.00392	CcSEcCtD
Betahistine—Skin disorder—Vinorelbine—ovarian cancer	0.0039	0.0039	CcSEcCtD
Betahistine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00388	0.00388	CcSEcCtD
Betahistine—Feeling abnormal—Topotecan—ovarian cancer	0.00387	0.00387	CcSEcCtD
Betahistine—Asthenia—Chlorambucil—ovarian cancer	0.00378	0.00378	CcSEcCtD
Betahistine—Pruritus—Chlorambucil—ovarian cancer	0.00373	0.00373	CcSEcCtD
Betahistine—Urticaria—Topotecan—ovarian cancer	0.00373	0.00373	CcSEcCtD
Betahistine—Urticaria—Melphalan—ovarian cancer	0.00365	0.00365	CcSEcCtD
Betahistine—Diarrhoea—Chlorambucil—ovarian cancer	0.00361	0.00361	CcSEcCtD
Betahistine—Erythema multiforme—Paclitaxel—ovarian cancer	0.00359	0.00359	CcSEcCtD
Betahistine—Dyspnoea—Vinorelbine—ovarian cancer	0.00358	0.00358	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00356	0.00356	CcSEcCtD
Betahistine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00346	0.00346	CcSEcCtD
Betahistine—Fatigue—Vinorelbine—ovarian cancer	0.00346	0.00346	CcSEcCtD
Betahistine—Hypersensitivity—Topotecan—ovarian cancer	0.00346	0.00346	CcSEcCtD
Betahistine—Immune system disorder—Paclitaxel—ovarian cancer	0.00343	0.00343	CcSEcCtD
Betahistine—Hypersensitivity—Melphalan—ovarian cancer	0.00338	0.00338	CcSEcCtD
Betahistine—Asthenia—Topotecan—ovarian cancer	0.00337	0.00337	CcSEcCtD
Betahistine—Vomiting—Chlorambucil—ovarian cancer	0.00335	0.00335	CcSEcCtD
Betahistine—Pruritus—Topotecan—ovarian cancer	0.00332	0.00332	CcSEcCtD
Betahistine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00331	0.00331	CcSEcCtD
Betahistine—Asthenia—Melphalan—ovarian cancer	0.0033	0.0033	CcSEcCtD
Betahistine—Flatulence—Paclitaxel—ovarian cancer	0.00326	0.00326	CcSEcCtD
Betahistine—Pruritus—Melphalan—ovarian cancer	0.00325	0.00325	CcSEcCtD
Betahistine—Diarrhoea—Topotecan—ovarian cancer	0.00321	0.00321	CcSEcCtD
Betahistine—Urticaria—Vinorelbine—ovarian cancer	0.00319	0.00319	CcSEcCtD
Betahistine—Diarrhoea—Melphalan—ovarian cancer	0.00314	0.00314	CcSEcCtD
Betahistine—Nausea—Chlorambucil—ovarian cancer	0.00313	0.00313	CcSEcCtD
Betahistine—Dizziness—Topotecan—ovarian cancer	0.0031	0.0031	CcSEcCtD
Betahistine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00307	0.00307	CcSEcCtD
Betahistine—Erythema multiforme—Docetaxel—ovarian cancer	0.00304	0.00304	CcSEcCtD
Betahistine—Angioedema—Paclitaxel—ovarian cancer	0.00302	0.00302	CcSEcCtD
Betahistine—Vomiting—Topotecan—ovarian cancer	0.00298	0.00298	CcSEcCtD
Betahistine—Malaise—Paclitaxel—ovarian cancer	0.00298	0.00298	CcSEcCtD
Betahistine—Rash—Topotecan—ovarian cancer	0.00296	0.00296	CcSEcCtD
Betahistine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00296	0.00296	CcSEcCtD
Betahistine—Dermatitis—Topotecan—ovarian cancer	0.00295	0.00295	CcSEcCtD
Betahistine—Headache—Topotecan—ovarian cancer	0.00294	0.00294	CcSEcCtD
Betahistine—Vomiting—Melphalan—ovarian cancer	0.00292	0.00292	CcSEcCtD
Betahistine—Immune system disorder—Docetaxel—ovarian cancer	0.00291	0.00291	CcSEcCtD
Betahistine—Rash—Melphalan—ovarian cancer	0.0029	0.0029	CcSEcCtD
Betahistine—Dermatitis—Melphalan—ovarian cancer	0.00289	0.00289	CcSEcCtD
Betahistine—Asthenia—Vinorelbine—ovarian cancer	0.00288	0.00288	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00287	0.00287	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00287	0.00287	CcSEcCtD
Betahistine—Convulsion—Paclitaxel—ovarian cancer	0.00287	0.00287	CcSEcCtD
Betahistine—Pruritus—Vinorelbine—ovarian cancer	0.00284	0.00284	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.0028	0.0028	CcSEcCtD
Betahistine—Nausea—Topotecan—ovarian cancer	0.00279	0.00279	CcSEcCtD
Betahistine—Discomfort—Paclitaxel—ovarian cancer	0.00278	0.00278	CcSEcCtD
Betahistine—Diarrhoea—Vinorelbine—ovarian cancer	0.00275	0.00275	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—ovarian cancer	0.00273	0.00273	CcSEcCtD
Betahistine—Nausea—Melphalan—ovarian cancer	0.00273	0.00273	CcSEcCtD
Betahistine—Confusional state—Paclitaxel—ovarian cancer	0.00272	0.00272	CcSEcCtD
Betahistine—Asthma—Epirubicin—ovarian cancer	0.00271	0.00271	CcSEcCtD
Betahistine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.0027	0.0027	CcSEcCtD
Betahistine—Dizziness—Vinorelbine—ovarian cancer	0.00265	0.00265	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00265	0.00265	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00265	0.00265	CcSEcCtD
Betahistine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00265	0.00265	CcSEcCtD
Betahistine—Tachycardia—Paclitaxel—ovarian cancer	0.00263	0.00263	CcSEcCtD
Betahistine—Skin disorder—Paclitaxel—ovarian cancer	0.00262	0.00262	CcSEcCtD
Betahistine—Vomiting—Vinorelbine—ovarian cancer	0.00255	0.00255	CcSEcCtD
Betahistine—Rash—Vinorelbine—ovarian cancer	0.00253	0.00253	CcSEcCtD
Betahistine—Dermatitis—Vinorelbine—ovarian cancer	0.00253	0.00253	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—ovarian cancer	0.00253	0.00253	CcSEcCtD
Betahistine—Headache—Vinorelbine—ovarian cancer	0.00251	0.00251	CcSEcCtD
Betahistine—Asthma—Doxorubicin—ovarian cancer	0.00251	0.00251	CcSEcCtD
Betahistine—Convulsion—Docetaxel—ovarian cancer	0.00243	0.00243	CcSEcCtD
Betahistine—Dyspnoea—Paclitaxel—ovarian cancer	0.00241	0.00241	CcSEcCtD
Betahistine—Somnolence—Paclitaxel—ovarian cancer	0.0024	0.0024	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.0024	0.0024	CcSEcCtD
Betahistine—Nausea—Vinorelbine—ovarian cancer	0.00238	0.00238	CcSEcCtD
Betahistine—Dyspepsia—Paclitaxel—ovarian cancer	0.00238	0.00238	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00237	0.00237	CcSEcCtD
Betahistine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Betahistine—Fatigue—Paclitaxel—ovarian cancer	0.00233	0.00233	CcSEcCtD
Betahistine—Confusional state—Docetaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00229	0.00229	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—ovarian cancer	0.00224	0.00224	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—ovarian cancer	0.00223	0.00223	CcSEcCtD
Betahistine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00222	0.00222	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—ovarian cancer	0.00222	0.00222	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00222	0.00222	CcSEcCtD
Betahistine—Urticaria—Paclitaxel—ovarian cancer	0.00214	0.00214	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—ovarian cancer	0.00205	0.00205	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—ovarian cancer	0.00204	0.00204	CcSEcCtD
Betahistine—Somnolence—Docetaxel—ovarian cancer	0.00203	0.00203	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—ovarian cancer	0.00201	0.00201	CcSEcCtD
Betahistine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00199	0.00199	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Betahistine—Fatigue—Docetaxel—ovarian cancer	0.00197	0.00197	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Betahistine—Asthenia—Paclitaxel—ovarian cancer	0.00194	0.00194	CcSEcCtD
Betahistine—Pruritus—Paclitaxel—ovarian cancer	0.00191	0.00191	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—ovarian cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—ovarian cancer	0.00189	0.00189	CcSEcCtD
Betahistine—Flatulence—Epirubicin—ovarian cancer	0.00186	0.00186	CcSEcCtD
Betahistine—Diarrhoea—Paclitaxel—ovarian cancer	0.00185	0.00185	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—ovarian cancer	0.00182	0.00182	CcSEcCtD
Betahistine—Dizziness—Paclitaxel—ovarian cancer	0.00178	0.00178	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Betahistine—Vomiting—Paclitaxel—ovarian cancer	0.00172	0.00172	CcSEcCtD
Betahistine—Malaise—Epirubicin—ovarian cancer	0.00171	0.00171	CcSEcCtD
Betahistine—Rash—Paclitaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Betahistine—Dermatitis—Paclitaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Betahistine—Headache—Paclitaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—ovarian cancer	0.00169	0.00169	CcSEcCtD
Betahistine—Asthenia—Docetaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Convulsion—Epirubicin—ovarian cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Pruritus—Docetaxel—ovarian cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Nausea—Paclitaxel—ovarian cancer	0.0016	0.0016	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.0016	0.0016	CcSEcCtD
Betahistine—Discomfort—Epirubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Betahistine—Malaise—Doxorubicin—ovarian cancer	0.00158	0.00158	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—ovarian cancer	0.00157	0.00157	CcSEcCtD
Betahistine—Confusional state—Epirubicin—ovarian cancer	0.00156	0.00156	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—ovarian cancer	0.00152	0.00152	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Betahistine—Dizziness—Docetaxel—ovarian cancer	0.00151	0.00151	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—ovarian cancer	0.00151	0.00151	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00148	0.00148	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—ovarian cancer	0.00147	0.00147	CcSEcCtD
Betahistine—Vomiting—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Betahistine—Rash—Docetaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—ovarian cancer	0.00144	0.00144	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Betahistine—Headache—Docetaxel—ovarian cancer	0.00143	0.00143	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00143	0.00143	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—ovarian cancer	0.0014	0.0014	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Betahistine—Somnolence—Epirubicin—ovarian cancer	0.00137	0.00137	CcSEcCtD
Betahistine—Nausea—Docetaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—ovarian cancer	0.00136	0.00136	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Betahistine—Fatigue—Epirubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—ovarian cancer	0.00126	0.00126	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Betahistine—Urticaria—Epirubicin—ovarian cancer	0.00123	0.00123	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—ovarian cancer	0.00118	0.00118	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Betahistine—Asthenia—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Betahistine—Pruritus—Epirubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Betahistine—Dizziness—Epirubicin—ovarian cancer	0.00102	0.00102	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—ovarian cancer	0.00101	0.00101	CcSEcCtD
Betahistine—Vomiting—Epirubicin—ovarian cancer	0.000981	0.000981	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—ovarian cancer	0.000977	0.000977	CcSEcCtD
Betahistine—Rash—Epirubicin—ovarian cancer	0.000973	0.000973	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—ovarian cancer	0.000972	0.000972	CcSEcCtD
Betahistine—Headache—Epirubicin—ovarian cancer	0.000967	0.000967	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—ovarian cancer	0.000944	0.000944	CcSEcCtD
Betahistine—Nausea—Epirubicin—ovarian cancer	0.000917	0.000917	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—ovarian cancer	0.000908	0.000908	CcSEcCtD
Betahistine—Rash—Doxorubicin—ovarian cancer	0.0009	0.0009	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—ovarian cancer	0.000899	0.000899	CcSEcCtD
Betahistine—Headache—Doxorubicin—ovarian cancer	0.000894	0.000894	CcSEcCtD
Betahistine—Nausea—Doxorubicin—ovarian cancer	0.000848	0.000848	CcSEcCtD
